Krishna Rocha Singh, MD
Interventional Cardiology · Springfield, ILNPI 1508948530
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 75.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $12,289 and has fallen 99.4% since, to $75 in 2024.
Across 35 payments — averaging $719.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Bard Peripheral Vascular, Inc.$4K
- Philips North America LLC$2K
- GE HealthCare$75
- Integra Lifesciences Corporation$50
- Welch Allyn$42
- plus $17 from 1 others
Across 13 payments — averaging $127,133 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.6M
- Boston Scientific$51K
What the payments were for
- Consulting fees$9,20037%
- Speaking & faculty fees$13,80055%
- Travel & lodging$3781%
- Food & beverage$1,7637%
- Gifts$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 27 | $19,080 |
| Bard Peripheral Vascular, Inc. | 2 | $4,098 |
| Philips North America LLC | 2 | $1,821 |
| GE HealthCare | 1 | $75 |
| Integra Lifesciences Corporation | 1 | $50 |
| Welch Allyn | 1 | $42 |
| Amgen | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IN.PACT Admiral$12,662
- WAVELINQ$4,050
- FlowMet-R$3,200
- Spectranetics Undiv$1,750
- HawkOne$1,600
- Endurant$503
- ELLIPSYS VASCULAR ACCESS SYSTEM$237
- VIVA XT CRT-D$188
How this compares
$25,183 in reported general payments places this provider in the 80th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 50 | $49,392 |
| EntrestoSacubitril/Valsartan | 56 | $48,546 |
| EliquisApixaban | 26 | $25,527 |
| FarxigaDapagliflozin Propanediol | 25 | $15,205 |
| Nitroglycerin PatchNitroglycerin | 22 | $1,652 |
| Carvedilol | 77 | $810 |
| Metoprolol Succinate | 60 | $692 |
| Losartan Potassium | 54 | $371 |
| Amlodipine Besylate | 83 | $341 |
| Nitroglycerin | 15 | $335 |
| Lisinopril | 41 | $194 |
| Furosemide | 49 | $192 |
| Chlorthalidone | 18 | $190 |
| ClopidogrelClopidogrel Bisulfate | 34 | $187 |
| Spironolactone | 47 | $169 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Springfield
- Tony de MartiniSpringfield$208K
- Shady HenienSpringfield$105K
- Donald YakelSpringfield$54K
- Jack HallSpringfield$40K
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
- Neal SawlaniPark Ridge$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.